Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
Lean patients with MASLD have worse liver outcomes and greater risk of all-cause mortality, but similar risk of HCC and extrahepatic cancer, and lower CVD risk.
Authors
- Shuohua Chen (ORCID: https://orcid.org/0000-0002-6274-7471)
- Zhirong Yang (ORCID: https://orcid.org/0000-0002-1562-0603)
- Ming‐Hua Zheng (ORCID: https://orcid.org/0000-0003-4984-2631)
- Canqing Yu (ORCID: https://orcid.org/0000-0002-0019-0014)
- Shengtao Zhu (ORCID: https://orcid.org/0000-0002-2795-8943)
- Yuanjie Pang
- Shouling Wu (ORCID: https://orcid.org/0000-0001-7095-6022)
- Shanshan Wu (ORCID: https://orcid.org/0000-0001-9791-8093)
- Yujun Long (ORCID: https://orcid.org/0000-0001-9458-8068)
- Qian Zhang (ORCID: https://orcid.org/0000-0001-8337-0928)
- Guodong Wang (ORCID: https://orcid.org/0000-0002-0422-8999)
- Liming Li (ORCID: https://orcid.org/0000-0002-2898-6188)
- Yating Huang (ORCID: https://orcid.org/0000-0002-8679-0001)
- Dianjianyi Sun
- Zhenyu Huo (ORCID: https://orcid.org/0009-0002-7745-8813)
- Jun Lv
- Yijun Chen (ORCID: https://orcid.org/0000-0003-1329-2527)
Institutions
- Peking University (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Kailuan General Hospital (CN)
- Institute for Advanced Study (DE)
- Shenzhen Institutes of Advanced Technology (CN)
- Shenzhen Technology University (CN)
Publication Details
- Journal
- Gut
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1136/gutjnl-2025-336127
- Citations
- 6
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 8.13